Lysine Decorated Solid Lipid Nanoparticles of Epirubicin for Cancer Targeting and Therapy

Parvaneh Bayat ¹ , Parvaneh Pakravan ¹ * , Mojtaba Salouti ², Jafar Ezzati Nazhad Dolatabadi ³

Cited by CrossRef: 16

1- Chakraborty S, Dhibar M, Das A, Swain K, Pattnaik S. A Critical Appraisal of Lipid Nanoparticles Deployed in Cancer Pharmacotherapy. RADDF. 2023;17(2):132 [Crossref]

2- Prajapati A, Rangra S, Patil R, Desai N, Jyothi V, Salave S, Amate P, Benival D, Kommineni N. Receptor-Targeted Nanomedicine for Cancer Therapy. Receptors. 2024;3(3):323 [Crossref]

3- Ying N, Lin X, Xie M, Zeng D. Effect of surface ligand modification on the properties of anti-tumor nanocarrier. Colloids and Surfaces B: Biointerfaces. 2022;220:112944 [Crossref]

4- Moraes-Lacerda T, de Jesus M. Mechanisms of solid lipid nanoparticles-triggered signaling pathways in eukaryotic cells. Colloids and Surfaces B: Biointerfaces. 2022;220:112863 [Crossref]

5- Banthia P, Gambhir L, Sharma A, Daga D, Kapoor N, Chaudhary R, Sharma G. Nano to rescue: repository of nanocarriers for targeted drug delivery to curb breast cancer. 3 Biotech. 2022;12(3) [Crossref]

6- More S, Wadhokar A, Bedjawalge R. A Review on Solid Lipid Nanoparticles as Nano Drug Delivery Transporters. CNANO. 2024;20(5):644 [Crossref]

7- Luiz M, Dutra J, Di Filippo L, Junior A, Tofani L, Marchetti J, Chorilli M. Epirubicin: Biological Properties, Analytical Methods, and Drug Delivery Nanosystems. Critical Reviews in Analytical Chemistry. 2023;53(5):1080 [Crossref]

8- Mottaqi M, Langarizadeh M, Molaali N, Rezaei M, Ameri A, Forootanfar H. The synthesis, application and therapeutic perspectives of medicinal plants-based solid lipid nanoparticles: a comprehensive review. ADV TRADIT MED (ADTM). 2024; [Crossref]

9- Behl A, Chhillar A. Nano-Based Drug Delivery of Anticancer Chemotherapeutic Drugs Targeting Breast Cancer. PRA. 2023;18(3):325 [Crossref]

10- Soltani A, Pakravan P. Preparation and Characterization of Magnetic Solid Lipid Nanoparticles as a Targeted Drug Delivery System for Doxorubicin. Adv Pharm Bull. 2023;13(2):301 [Crossref]

11- Li K, Pi C, Wen J, He Y, Yuan J, Shen H, Zhao W, Zeng M, Song X, Lee R, Wei Y, Zhao L. Formulation of the novel structure curcumin derivative–loaded solid lipid nanoparticles: synthesis, optimization, characterization and anti-tumor activity screening in vitro. Drug Delivery. 2022;29(1):2044 [Crossref]

12- Nguyen T, Pham K, Yook S. Engineered therapeutic proteins for sustained-release drug delivery systems. Acta Biomaterialia. 2023;171:131 [Crossref]

13- Rahman M, Afzal O, Ullah S, Alshahrani M, Alkhathami A, Altamimi A, Almujri S, Almalki W, Shorog E, Alossaimi M, Mandal A, abdulrahman A, Sahoo A. Nanomedicine-Based Drug-Targeting in Breast Cancer: Pharmacokinetics, Clinical Progress, and Challenges. ACS Omega. 2023;8(51):48625 [Crossref]

14- Kaur N, Popli P, Tiwary N, Swami R. Small molecules as cancer targeting ligands: Shifting the paradigm. Journal of Controlled Release. 2023;355:417 [Crossref]